🇺🇸 FDA
Patent

US 8871925

Compositions of novel carbohydrate drug for treatment of human diseases

granted A61KA61K31/70A61K31/715

Quick answer

US patent 8871925 (Compositions of novel carbohydrate drug for treatment of human diseases) held by GALECTIN THERAPEUTICS, INC. expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GALECTIN THERAPEUTICS, INC.
Grant date
Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/70, A61K31/715, A61K31/738, A61K45/06